Cigna Reports 2016 Results, Expects Attractive Earnings Growth in 2017

BLOOMFIELD, Conn., 02 February, 2017 - Cigna Corporation (NYSE: CI) today reported 2016 results with a solid fourth quarter performance, and projecting attractive earnings growth in 2017.

“We concluded 2016 with strong momentum that positions the company for attractive earnings and customer growth in 2017,” said David M. Cordani, President and Chief Executive Officer. “We continue to deliver differentiated value for our customers and clients with innovative solutions that drive greater levels of affordability and personalization.”

Total revenues for 2016 were $39.7 billion, an increase of 5% over 2015, driven by continued growth in Cigna's targeted customer segments.

Shareholders’ net income for 2016 was $1.9 billion, or $7.19 per share, compared with $2.1 billion, or $8.04 per share in 2015. For the fourth quarter of 2016, shareholders’ net income was $382 million, or $1.47 per share, compared with $426 million, or $1.64 per share, for the fourth quarter of 2015.

Cigna's adjusted income from operations1 for full year 2016 was $2.1 billion, or $8.10 per share, compared with $2.3 billion, or $8.66 per share, for full year 2015. For the fourth quarter of 2016, adjusted income from operations1 was $485 million, or $1.87 per share, compared with $486 million, or $1.87 per share, for the fourth quarter of 2015. Adjusted income from operations1 for the full year and the fourth quarter of 2016 reflect continued strong results in our Commercial Healthcare and Global Supplemental Benefits businesses, and actions we have taken to improve results in our Seniors and Disability & Life businesses.

Reconciliations of shareholders’ net income to adjusted income from operations1 are provided on the following page, and on Exhibit 2 of this earnings release.

CONSOLIDATED HIGHLIGHTS

The following table includes highlights of results and reconciliations of consolidated operating revenues5 to total revenues and adjusted income from operations1 to shareholders’ net income:

Consolidated Financial Results (dollars in millions):  
      Year
Three Months Ended Ended
December 31, September 30, December 31,
  2016     2015     2016     2016
 
Total Revenues $ 9,944 $ 9,528 $ 9,880 $ 39,668
Net realized investment (gains) losses   (59)     47     (75)     (169)
Consolidated Operating Revenues5 $ 9,885 $ 9,575 $ 9,805 $ 39,499
 
Consolidated Earnings, net of taxes
Shareholders’ net income $ 382 $ 426 $ 456 $ 1,867
Net realized investment (gains) losses (38) 28 (48) (109)
Amortization of other acquired intangible assets1 22 4 24 94
Special items1   119     28     71     252
Adjusted income from operations1 $ 485   $ 486   $ 503   $ 2,104
 
Shareholders’ net income, per share $ 1.47   $ 1.64   $ 1.76   $ 7.19
Adjusted income from operations1, per share $ 1.87   $ 1.87   $ 1.94   $ 8.10

HIGHLIGHTS OF SEGMENT RESULTS

See Exhibit 2 for a reconciliation of adjusted income (loss) from operations1 to shareholders’ net income.

Global Health Care

This segment includes Cigna’s Commercial and Government businesses that deliver medical and specialty health care products and services to domestic and multi-national clients and customers using guaranteed cost, retrospectively experience-rated and administrative services only (“ASO”) funding arrangements. Specialty health care includes behavioral, dental, disease and medical management, stop loss and pharmacy-related products and services.

Financial Results (dollars in millions, customers in thousands):    
    Year
Three Months Ended Ended
December 31,

 

September 30,

December 31,
  2016     2015     2016     2016
 
Premiums and Fees $ 6,857 $ 6,721 $ 6,807 $ 27,663
Adjusted Income from Operations1 $ 406 $ 394 $ 416 $ 1,852
Adjusted Margin, After-Tax6 5.2% 5.2% 5.4% 5.9%
 
As of the Periods Ended
December 31,

 

September 30,

Customers:

  2016     2015     2016  
Commercial 14,631 14,432 14,594
Government   566     567     583  
Medical 15,197 14,999 15,177
 
Behavioral Care 26,238 24,674 26,102
Dental 14,981 13,869 14,960
Pharmacy 8,461 8,068 8,370
Medicare Part D 972 1,476 999

Global Supplemental Benefits

This segment includes Cigna’s global individual supplemental health, life and accident insurance business, primarily in Asia, and Medicare supplement coverage in the United States.

Financial Results (dollars in millions, policies in thousands):

        Year
Three Months Ended Ended
December 31, September 30, December 31,
  2016     2015     2016     2016
 
Premiums and Fees9 $ 842 $ 776 $ 833 $ 3,247
Adjusted Income from Operations1 $ 63 $ 54 $ 81 $ 294
Adjusted Margin, After-Tax6 7.2% 6.7% 9.4% 8.7%
 
As of the Periods Ended
December 31, September 30,
  2016     2015     2016
 
Policies9 12,151 12,888 12,069

Group Disability and Life

This segment includes Cigna’s group disability, life and accident insurance operations.

Financial Results (dollars in millions):

        Year
Three Months Ended Ended
December 31,

 

September 30,

December 31,
  2016     2015    

2016

    2016
 
Premiums and Fees $ 1,035 $ 998 $ 1,024 $ 4,098
Adjusted Income from Operations1 $ 69 $ 83 $ 53 $ 125
Adjusted Margin, After-Tax6 6.1% 7.6% 4.8% 2.8%

Corporate & Other Operations

Adjusted loss from operations1 for Cigna's remaining operations is presented below:

Financial Results (dollars in millions):

             
    Year
Three Months Ended Ended
December 31,

 

September 30,

December 31,
  2016     2015    

2016

    2016
 
Corporate & Other Operations $ (53) $ (45) $ (47) $ (167)

2017 OUTLOOK

Cigna's outlook for full year 2017 consolidated adjusted income from operations1,3 is in the range of $2.35 billion to $2.48 billion, or $9.00 to $9.50 per share. Cigna’s outlook excludes the impact of additional prior year reserve development and potential effects of any future capital deployment.4

(dollars in millions, except where noted and per share amounts)

  Projection for Full-Year Ending
December 31, 2017
 
Adjusted Income (Loss) from Operations 1,3
Global Health Care $ 2,035 to 2,115
Global Supplemental Benefits $ 295 to 315
Group Disability and Life $ 200 to 230
Ongoing Businesses $ 2,530 to 2,660
 
Corporate & Other Operations $ (180)
Consolidated Adjusted Income from Operations1,3 $ 2,350 to 2,480
 
Consolidated Adjusted Income from Operations, per share1,3,4 $ 9.00 to 9.50
 

2017 Operating Metrics and Ratios Outlook

Total Revenue Growth

2% to 3%

 
Full Year Total Commercial Medical Care Ratio 7 80.5% to 81.5%

Full Year Total Government Medical Care Ratio 7

85% to 86%

Full Year Global Health Care Operating Expense Ratio 7

20.5% to 21.5%

Global Medical Customer Growth 2

300,000 – 500,000 customers

The foregoing statements represent the Company’s current estimates of Cigna's 2017 consolidated and segment adjusted income from operations1,3 and other key metrics as of the date of this release. Actual results may differ materially depending on a number of factors. Investors are urged to read the Cautionary Note Regarding Forward-Looking Statements included in this release. Management does not assume any obligation to update these estimates.

This quarterly earnings release and the Quarterly Financial Supplement are available on Cigna’s website in the Investor Relations section (http://www.cigna.com/aboutcigna/investors). A link to the conference call, during which management will review fourth quarter 2016 results and discuss full year 2017 outlook, is available in the Investor Relations section of Cigna's website located at http://www.cigna.com/cignadotcom/aboutcigna/investors/events/index.page

Notes:

   

1.

 

Adjusted income (loss) from operations is defined as shareholders’ net income (loss) excluding the following after-tax adjustments: net realized investment results, net amortization of other acquired intangible assets and special items. Net amortization of other acquired intangible assets in 2015 included the one-time benefit of an acquisition in which the fair value of acquired net assets exceeded the purchase price. Special items are identified in Exhibit 2 of this earnings release.

 

Adjusted income (loss) from operations is a measure of profitability used by Cigna’s management because it presents the underlying results of operations of Cigna’s businesses and permits analysis of trends in underlying revenue, expenses and shareholders’ net income. This consolidated measure is not determined in accordance with accounting principles generally accepted in the United States (GAAP) and should not be viewed as a substitute for the most directly comparable GAAP measure, shareholders’ net income. See Exhibits 1 and 2 for a reconciliation of adjusted income from operations to shareholders’ net income.

 

2.

Global medical customers include individuals who meet any one of the following criteria: are covered under a medical insurance policy, managed care arrangement, or service agreement issued by Cigna; have access to Cigna's provider network for covered services under their medical plan; or have medical claims and services that are administered by Cigna.

 

3.

Management is not able to provide a reconciliation to shareholders’ net income (loss) on a forward-looking basis because we are unable to predict, without unreasonable effort, certain components thereof including (i) future net realized investment results and (ii) future special items. These items are inherently uncertain and depend on various factors, many of which are beyond our control. As such, any associated estimate and its impact on shareholders’ net income could vary materially. The Company believes it is reasonably likely that a guaranty fund assessment related to Penn Treaty Network America Insurance Company and its subsidiary American Network Insurance Company will be finalized in 2017. Due to uncertainties surrounding this matter, the Company’s share of this guaranty fund assessment is uncertain, but based on current information, is estimated to be approximately $85 million after tax. The Company expects to treat this guaranty fund assessment as a special item.

 

4.

The Company’s outlook excludes the potential effects of any share repurchases or business combinations that may occur after the date of this earnings release.

 

5.

The measure “consolidated operating revenues” is not determined in accordance with GAAP and should not be viewed as a substitute for the most directly comparable GAAP measure, “total revenues.” We define consolidated operating revenues as total revenues excluding realized investment results. We exclude realized investment results from this measure because our portfolio managers may sell investments based on factors largely unrelated to the underlying business purposes of each segment. As a result, gains or losses created in this process may not be indicative of past or future underlying performance of the business. See Exhibit 1 for a reconciliation of consolidated operating revenues to total revenues.

 

6.

Adjusted margin, after-tax, is calculated by dividing adjusted income (loss) from operations by operating revenues for each segment.

 

7.

Operating ratios are defined as follows:

Total Commercial medical care ratio represents medical costs as a percentage of premiums for all commercial risk products, including medical, pharmacy, dental, stop loss and behavioral products provided through guaranteed cost or experience-rated funding arrangements in both the United States and internationally.

Total Government medical care ratio represents medical costs as a percentage of premiums for Medicare Advantage, Medicare Part D, and Medicaid products.

Global Health Care Operating Expense Ratio represents operating expenses excluding acquisition related amortization expense as a percentage of operating revenue in the Global Health Care segment.

 

8.

Global Health Care medical costs payable are presented net of reinsurance and other recoverables. The gross Global Health Care medical costs payable balance was $2.53 billion as of December 31, 2016 and $2.36 billion as of December 31, 2015.

 

9.

Cigna owns a 50% noncontrolling interest in its China joint venture. Cigna's 50% share of the joint venture’s earnings is reported in Other Revenues using the equity method of accounting under GAAP. As such, the premiums and fees and policy counts for the Global Supplemental Benefits segment do not include the China joint venture.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release, and oral statements made with respect to information contained in this release, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on Cigna's current expectations and projections about future trends, events and uncertainties. These statements are not historical facts. Forward-looking statements may include, among others, statements concerning our projected adjusted income (loss) from operations outlook for 2017, on both a consolidated and segment basis; projected total revenue growth and global medical customer growth, each over year end 2016; projected medical care and operating expense ratios and medical cost trends; future financial or operating performance, including our ability to deliver personalized and innovative solutions for our customers and clients and future growth, business strategy, strategic or operational initiatives; economic, regulatory or competitive environments, particularly with respect to the pace and extent of change in these areas; financing or capital deployment plans and amounts available for future deployment; our prospects for growth in the coming years; statements regarding the proposed merger between Cigna and Anthem, Inc. (Anthem); statements regarding the timing of resolution of the issues raised by CMS; and other statements regarding Cigna’s and Anthem’s future beliefs, expectations, plans intentions, financial condition or performance. You may identify forward-looking statements by the use of words such as “believe,” “expect,” “plan,” “intend,” “anticipate,” “estimate,” “predict,” “potential,” “may,” “should,” “will” or other words or expressions of similar meaning, although not all forward-looking statements contain such terms.

Forward-looking statements are subject to risks and uncertainties, both known and unknown, that could cause actual results to differ materially from those expressed or implied in forward-looking statements. Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes, including those in our disability business; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions; the substantial level of government regulation over our business and the potential effects of new laws or regulations, or changes in existing laws or regulations; the outcome of litigation, regulatory audits, including the CMS review and sanctions, investigations and actions and/or guaranty fund assessments; uncertainties surrounding participation in government-sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; and unfavorable industry, economic or political conditions, including foreign currency movements; the timing and likelihood of completion of the proposed merger, including the timing, receipt and terms and conditions of any required governmental and regulatory approvals for the proposed merger that could reduce anticipated benefits or cause the parties to abandon the transaction; the possibility that the expected synergies and value creation from the proposed merger will not be realized or will not be realized within the expected time period; the risk that the businesses of Cigna and Anthem will not be integrated successfully; disruption from the proposed merger making it more difficult to maintain business and operational relationships; the risk that unexpected costs will be incurred; the possibility that the proposed merger does not close, including due to the failure to satisfy the closing conditions; the risk that financing for the proposed merger may not be available on favorable terms, as well as more specific risks and uncertainties discussed in our most recent report on Form 10-K and subsequent reports on Forms 10-Q and 8-K available on the Investor Relations section of www.cigna.com as well as on Anthem’s most recent report on Form 10-K and subsequent reports on Forms 10-Q and 8-K available on the Investor Relations section of www.antheminc.com. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made, are not guarantees of future performance or results, and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Cigna undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by law.

CIGNA CORPORATION        
COMPARATIVE SUMMARY OF FINANCIAL RESULTS (unaudited) Exhibit 1
(Dollars in millions, except per share amounts)
 
 
                     
Three Months Ended Year Ended
December 31, December 31,
      2016     2015         2016     2015
 
REVENUES
 
Premiums $ 7,621 $ 7,461 $ 30,626 $ 29,642
Fees 1,139 1,056 4,485 4,217
Net investment income 299 295 1,147 1,153
Mail order pharmacy revenues 759 690 2,966 2,536
Other revenues   67   73   275   271
Consolidated operating revenues 9,885 9,575 39,499 37,819
Net realized investment gains (losses) 59 (47) 169 57
                     
Total revenues   $ 9,944   $ 9,528       $ 39,668   $ 37,876
 
SHAREHOLDERS' NET INCOME (LOSS)
 
Shareholders' net income $ 382 $ 426 $ 1,867 $ 2,094
After-tax adjustments to reconcile to adjusted income from operations:
Realized investment (gains) losses (38) 28 (109) (40)
Amortization of other acquired intangible assets, net 22 4 94 80
Special items 119 28 252 122
                     
Adjusted income from operations (1)     485   $ 486       $ 2,104   $ 2,256
 

Adjusted income (loss) from operations by segment

Global Health Care $ 406 $ 394 $ 1,852 $ 1,848
Global Supplemental Benefits 63 54 294 262
Group Disability and Life   69   83   125   324
Ongoing Operations 538 531 2,271 2,434
Corporate and Other (53) (45) (167) (178)
                     
Total adjusted income from operations   $ 485   $ 486       $ 2,104   $ 2,256
 
DILUTED EARNINGS PER SHARE
 
Shareholders' net income $ 1.47 $ 1.64 $ 7.19 $ 8.04
After-tax adjustments to reconcile to adjusted income from operations:
Realized investment (gains) losses (0.14) 0.11 (0.42) (0.15)
Amortization of other acquired intangible assets, net 0.08 0.01 0.36 0.30
Special items 0.46 0.11 0.97 0.47
                     
Adjusted income from operations (1)   $ 1.87   $ 1.87       $ 8.10   $ 8.66
Weighted average shares (in thousands)     259,882     260,518         259,647     260,592
Common shares outstanding (in thousands)                 256,869     256,544
 
SHAREHOLDERS' EQUITY at December 31,               $ 13,723   $ 12,035
 
SHAREHOLDERS' EQUITY PER SHARE at December 31,             $ 53.42   $ 46.91
 

(1) Adjusted income (loss) from operations is defined as shareholders' net income (loss) excluding the following after-tax adjustments: realized investment results; net amortization of other acquired intangible assets; and special items (identified and quantified on Exhibit 2).

CIGNA CORPORATION                                    
RECONCILIATION OF SHAREHOLDERS' NET INCOME (LOSS) TO ADJUSTED INCOME FROM OPERATIONS                           Exhibit 2      
(Dollars in millions, except per share amounts)
Diluted Global Group Corporate
Earnings Global Supplemental Disability and
Per Share Consolidated Health Care Benefits and Life Other

Three Months Ended,

4Q16   4Q15   3Q16   4Q16   4Q15   3Q16   4Q16   4Q15   3Q16   4Q16   4Q15   3Q16   4Q16   4Q15   3Q16   4Q16   4Q15   3Q16
 
Shareholders' net income (loss) $ 1.47 $   1.64 $   1.76 $   382 $   426 $   456 $   337 $   354 $   413 $   54 $   72 $   77 $   83 $   74 $   65 $   (92) $   (74) $   (99)
After-tax adjustments to reconcile to adjusted income from operations:
Realized investment (gains) losses (0.14) 0.11 (0.19) (38) 28 (48) (29) 20 (42) 5 (2) - (14) 9 (12) - 1 6
Amortization of other acquired intangible assets, net 0.08 0.01 0.09 22 4 24 18 20 20 4 (16) 4 - - - - - -
Special items:
Charges associated with litigation matters - - 0.10 - - 25 - - 25 - - - - - - - - -
Merger-related transaction costs 0.15 0.11 0.18 39 28 46 - - - - - - - - - 39 28 46
Risk corridor allowance   0.31       -       -       80       -       -       80       -       -       -       -       -       -       -       -       -       -       -  
Adjusted income (loss) from operations $ 1.87   $   1.87   $   1.94   $   485   $   486   $   503   $   406   $   394   $   416   $   63   $   54   $   81   $   69   $   83   $   53   $   (53)   $   (45)   $   (47)  
Weighted average shares (in thousands) 259,882 260,518 259,754
 
Special Items, pre-tax:
Charges associated with litigation matters $ - $ - $ 40 $ - $ - $ 40 $ - $ - $ - $ - $ - $ - $ - $ - $ -
Merger-related transaction costs 43 31 49 - - - - - - - - - 43 31 49
Risk corridor allowance     124       -       -       124       -       -       -       -       -       -       -       -       -       -       -  
Total $   167   $   31   $   89   $   124   $   -   $   40   $   -   $   -   $   -   $   -   $   -   $   -   $   43   $   31   $   49  
 
 
 
Diluted Global Group Corporate
Earnings Global Supplemental Disability and
Per Share Consolidated Health Care Benefits and Life Other
Year Ended December 31,   2016           2015   2016       2015   2016       2015   2016       2015   2016       2015   2016       2015  
 
Shareholders' net income (loss) $ 7.19 $ 8.04 $ 1,867 $ 2,094 $ 1,751 $ 1,794 $ 268 $ 267 $ 164 $ 328 $ (316) $ (295)
After-tax adjustments to reconcile to adjusted income from operations:
Realized investment (gains) losses (0.42) (0.15) (109) (40) (78) (30) 6 (1) (39) (4) 2 (5)
Amortization of other acquired intangible assets, net 0.36 0.30 94 80 74 84 20 (4) - - - -
Special Items:
Charges associated with litigation matters 0.10 - 25 - 25 - - - - - - -
Debt extinguishment costs - 0.25 - 65 - - - - - - - 65
Merger-related transaction costs 0.56 0.22 147 57 - - - - - - 147 57
Risk corridor allowance   0.31           -       80           -       80           -       -           -       -           -       -           -  
Adjusted income (loss) from operations $ 8.10       $   8.66   $   2,104       $   2,256   $   1,852       $   1,848   $   294       $   262   $   125       $   324   $   (167)       $   (178)  
Weighted average shares (in thousands) 259,647 260,592
Common shares outstanding as of December 31, (in thousands) 256,869 256,544
 
Special Items, pre-tax:
Charges associated with litigation matters $ 40 $ - $ 40 $ - $ - $ - $ - $ - $ - $ -
Debt extinguishment costs - 100 - - - - - - - 100
Merger-related transaction costs 166 66 - - - - - - 166 66
Risk corridor allowance     124           -       124           -       -           -       -           -       -           -  
Total $   330       $   166   $   164       $   -   $   -       $   -   $   -       $   -   $   166       $   166  

View source version on businesswire.com:http://cigna.newshq.businesswire.com/press-release/cigna-reports-2016-results-expects-attractive-earnings-growth-2017